Selected article for: "control group and curve area"
Title: 2015 ACVIM Forum Research Abstract Program
  • Document date: 2015_5_27
    • ID: 3pnuj5ru_3
    Snippet: Compared with control group, the fold-changes of the both target genes were significantly low in PDA (0.50 AE 0.17 for SER-CA2a and 0.41 AE 0.21 for PLN) as well as in PS (0.47 AE 0.20 for SERCA2a and 0.35 AE 0.10 for PLN). In paired comparison between pre-and post-operation, their expression levels significantly increased one week after surgical correction in both PDA (0.74 AE 0.22 for SERCA2a and 0.68 AE 0.24 for PLN) and PS (0.74 AE 0.18 for S.....
    Document: Compared with control group, the fold-changes of the both target genes were significantly low in PDA (0.50 AE 0.17 for SER-CA2a and 0.41 AE 0.21 for PLN) as well as in PS (0.47 AE 0.20 for SERCA2a and 0.35 AE 0.10 for PLN). In paired comparison between pre-and post-operation, their expression levels significantly increased one week after surgical correction in both PDA (0.74 AE 0.22 for SERCA2a and 0.68 AE 0.24 for PLN) and PS (0.74 AE 0.18 for SERCA2a and 0.65 AE 0.20 for PLN). Meanwhile, plasma levels of NT-proBNP between before and after surgery were not different in both PDA (before surgery, 761.0 AE 579.2 pmol/L; one week after surgery, 679.9 AE 437.2 pmol/L) and PS (before surgery, 867.2 AE 560.2 pmol/L; one week after surgery, 863.4 AE 523.1 pmol/L). Additionally, the expression levels of SER-CA2a and PLN were significantly correlated to hemodynamic indices, such as fractional shortening and LA/Ao ratio in PDA, and peak pressure gradient in PS (P < 0.05). Furthermore, receiveroperating characteristic analysis showed high values of the area under the curve in SERCA2a (0.95 AE 0.04 in PDA; 0.95 AE 0.04 in PS) and PLN (1.00 AE 0.0 in PDA; 0.98 AE 0.03 in PS).

    Search related documents:
    Co phrase search for related documents
    • characteristic analysis and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • characteristic analysis and expression level: 1, 2, 3, 4, 5, 6
    • characteristic analysis and hemodynamic index: 1
    • characteristic analysis and high value: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • characteristic analysis and peak pressure: 1
    • control group and expression level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • control group and fractional shortening: 1, 2, 3
    • control group and hemodynamic index: 1, 2, 3
    • control group and high value: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • control group and peak pressure: 1, 2, 3, 4
    • control group compare and expression level: 1
    • expression level and fold target gene change: 1
    • expression level and fractional shortening: 1
    • expression level and high value: 1, 2, 3, 4, 5
    • fractional shortening and LA Ao ratio: 1, 2, 3, 4
    • fractional shortening and LA Ao ratio fractional shortening: 1